Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma

K.M. Field, J. Simes, Anna Nowak, L. Cher, H. Wheeler, E.J. Hovey, C.S.B. Brown, E.H. Barnes, K. Sawkins, A. Livingstone, R. Freilich, P.M. Phal, G. Fitt, M.A. Rosenthal, I. Arzhintar, L. Garrett, A. Byrne, A. Dowling, N. Ranieri, R. JennensF. Osmond, W.K. Patterson, A. Phay, F. Abell, L. Plowman, J. Flynn, E. Hovey, H. Kilsby, S. Kirby-Lewis, N. Singhal, S. Smith, M. Whelan, P. Inglis, A. Ives, S. Lobb, S. Begbie, P. Williams, Z. Lwin, N. Woodward, G. Crosbie, R. Harrup, L. Pyszkowski, S. Gauden, A. Neville

Research output: Contribution to journalArticlepeer-review

115 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science